Invicta Diagnostic IPO Shows Strong Response, Subscribed 4.27x on Day 3

Invicta Diagnostic Limited's initial public offering (IPO) has demonstrated strong investor interest through its third day of subscription. The stock price band is set at ₹80-85 per share. 

Invicta Diagnostic IPO non-institutional investors segment leads with strong 6.96 times subscription. Qualified institutional buyers demonstrate moderate participation at 3.51 times. Individual investors display moderate interest at 3.44 times. 

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Invicta Diagnostic IPO subscription reached strong 4.27 times on day three. It was led by Non-Institutional Investors (6.96x), Qualified Institutional Buyers Ex-Anchor (3.51x), and Individual Investors (3.44x). 

Subscription Status of Invicta Diagnostic IPO:

Here are the subscription details for Invicta Diagnostic IPO as of Day 3 (December 3, 2025, 5:04:59 PM):

Key Highlights - Day 3:

• Overall subscription reached strong 4.27 times, showing substantial improvement from day two's 0.95 times
• Non-institutional investors displaying strong interest at 6.96 times, building dramatically from day two's 0.74 times, indicating healthy HNI appetite for this diagnostic services company
• Qualified institutional buyers (ex-anchor) showing moderate performance at 3.51 times, building substantially from day two's 1.55 times, indicating improved institutional interest in this Mumbai-based diagnostic chain
• Individual investors displaying moderate confidence at 3.44 times, building substantially from day two's 0.79 times, indicating improved retail demand for this SME IPO
• Cumulative bid amount reached ₹85.07 crores, significantly exceeding the net offer size of ₹26.71 crores (excluding anchor and market maker portions) by over 3 times
• Market makers fully subscribed their allocation of ₹1.41 crores

Invicta Diagnostic IPO - Day 2 Subscription at 0.95 Times

Key Highlights - Day 2:

• Overall subscription reached limited 0.95 times, showing modest improvement from day one's 0.54 times
• Qualified institutional buyers showing moderate performance at 1.55 times, building from day one's 1.00 times
• Individual investors displaying weak confidence at 0.79 times, building from day one's 0.29 times
• Non-institutional investors showing weak performance at 0.74 times, marginally improving from day one's 0.68 times

Invicta Diagnostic IPO - Day 1 Subscription at 0.54 Times

Key Highlights - Day 1:

• Overall subscription reached weak 0.54 times, showing cautious initial investor interest
• Qualified institutional buyers showing moderate performance at 1.00 times, indicating measured institutional appetite
• Non-institutional investors showing weak performance at 0.68 times, indicating subdued HNI interest
• Individual investors displaying weak confidence at 0.29 times, showing very weak retail sentiment

About Invicta Diagnostic Limited

Incorporated in January 2021, Invicta Diagnostic Limited (trading as PC Diagnostics) offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra. The Mumbai-based diagnostic services company specializes in integrated pathology and radiology solutions, following a hub-and-spoke model across the Mumbai Metropolitan Region.